 Electrophysiologic electrocardiographic effects efficacy safety encainide malignant ventricular arrhythmias coronary artery disease electrophysiologic electrocardiographic effects efficacy safety encainide patients coronary artery disease programmed stimulation ventricular tachyarrhythmias study group men women years mean standard deviation nonsustained ventricular tachycardia VT patients VT ventricular fibrillation unexplained syncope left ventricular ejection fraction arrhythmias baseline drug-free electrophysiologic study nonsustained VT patients VT ventricular fibrillation patients equal class IA combination class IA IB agents mean drugs encainide Oral encainide mean daily dose mg equal days repeat stimulation Encainide follow-up electrophysiologic testing patients due spontaneous development new patients undergoing electropharmacologic encainide inducible arrhythmia patients VT inducible extrastimuli patients stable VT cardioversion whereas patients VT inducible number extrastimuli induction VT ventricular fibrillation patients possible proarrhythmic effect patients patients inducible VT long-term encainide therapy weeks hospital discharge VT recurrence